U.S. MARSHALS SEIZE INFUSION PUMPS FROM CARDINAL HEALTH

Four models of Alaris Signature Edition Gold infusion pumps were seized at a manufacturing facility in Southern California, the FDA said Aug. 28.

Fulfilling an order issued by the U.S. District Court for the Southern District of California, U.S. marshals seized the pumps Aug. 25 at devicemaker Cardinal Health Care 303's plant in San Diego, the FDA said.

The devices were seized because of a design defect called "key bounce" that may cause potential over-infusion of medications, the agency said.

The FDA announcement on the pump seizure can be viewed at www.fda.gov/bbs/topics/NEWS/2006/NEW01437.html (http://www.fda.gov/bbs/topics/NEWS/2006/NEW01437.html).